Kunt T - Search Results

1

The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type I diabetes mellitus.

Kunt T, Schneider S, Pfützner A, Goitum K, Engelbach M, Schauf B, Beyer J, Forst T. Kunt T, et al. Diabetologia. 1999 Apr;42(4):465-71. doi: 10.1007/s001250051180. Diabetologia. 1999. PMID: 10230651

2

C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients.

Hach T, Forst T, Kunt T, Ekberg K, Pfützner A, Wahren J. Hach T, et al. Among authors: kunt t. Exp Diabetes Res. 2008;2008:730594. doi: 10.1155/2008/730594. Exp Diabetes Res. 2008. PMID: 18483566 Free PMC article.

3

Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus.

Forst T, Kunt T, Pohlmann T, Goitom K, Engelbach M, Beyer J, Pfützner A. Forst T, et al. Among authors: kunt t. J Clin Invest. 1998 May 15;101(10):2036-41. doi: 10.1172/JCI2147. J Clin Invest. 1998. PMID: 9593759 Free PMC article. Clinical Trial.

4

New aspects on biological activity of C-peptide in IDDM patients.

Forst T, Kunt T, Pfützner A, Beyer J, Wahren J. Forst T, et al. Among authors: kunt t. Exp Clin Endocrinol Diabetes. 1998;106(4):270-6. doi: 10.1055/s-0029-1212190. Exp Clin Endocrinol Diabetes. 1998. PMID: 9792458 Review.

5

Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I.

Forst T, De La Tour DD, Kunt T, Pfützner A, Goitom K, Pohlmann T, Schneider S, Johansson BL, Wahren J, Löbig M, Engelbach M, Beyer J, Vague P. Forst T, et al. Among authors: kunt t. Clin Sci (Lond). 2000 Mar;98(3):283-90. Clin Sci (Lond). 2000. PMID: 10677386 Clinical Trial.

6

Effects of C-peptide on microvascular blood flow and blood hemorheology.

Forst T, Kunt T. Forst T, et al. Among authors: kunt t. Exp Diabesity Res. 2004 Jan-Mar;5(1):51-64. doi: 10.1080/15438600490424532. Exp Diabesity Res. 2004. PMID: 15198371 Free PMC article. Review.

7

Clinical and laboratory evaluation of specific chemiluminescence assays for intact and total proinsulin.

Pfützner A, Kunt T, Langenfeld M, Löbig M, Knesovic M, Forst T. Pfützner A, et al. Among authors: kunt t. Clin Chem Lab Med. 2003 Sep;41(9):1234-8. doi: 10.1515/CCLM.2003.189. Clin Chem Lab Med. 2003. PMID: 14598875

8

Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide.

Wallerath T, Kunt T, Forst T, Closs EI, Lehmann R, Flohr T, Gabriel M, Schäfer D, Göpfert A, Pfützner A, Beyer J, Förstermann U. Wallerath T, et al. Among authors: kunt t. Nitric Oxide. 2003 Sep;9(2):95-102. doi: 10.1016/j.niox.2003.08.004. Nitric Oxide. 2003. PMID: 14623175

9

Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance.

Pfützner A, Langenfeld M, Kunt T, Löbig M, Forst T. Pfützner A, et al. Among authors: kunt t. Clin Lab. 2003;49(11-12):571-6. Clin Lab. 2003. PMID: 14651328

10

Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes.

Pfützner A, Kunt T, Hohberg C, Mondok A, Pahler S, Konrad T, Lübben G, Forst T. Pfützner A, et al. Among authors: kunt t. Diabetes Care. 2004 Mar;27(3):682-7. doi: 10.2337/diacare.27.3.682. Diabetes Care. 2004. PMID: 14988285

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters